LADRX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.2 USD | +8.99% |
|
+15.94% | +146.15% |
| 04/06 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
| 15/05 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
5d24a6b6d58d7b0879f9c3.lW4KU8gnN35pokja0_hvRtPaGKdCs4vdk-sAoCBpEbM.2FdcNZBDQBgbxQ6rq5MqDrGvVZct5Nzr3b96xmQBdP3YIlNiiXJ8OTzJGQ~4da6ae251f8d690b58b8f73a3fb27b09
